Matrix metalloproteinase-1 polymorphism in Taiwanese patients with endobronchial tuberculosis

Tuberculosis

Volumn 88, Issue 3, 2008, Pages 262-267

  Kuo, Han Pin ^a   Wang, Yu Min ^a   Wang, Chun Hua ^a   He, Chih Chen ^a   Lin, Shu Min ^a   Lin, Horng Chyuan ^a   Liu, Chien Ying ^a   Huang, Kuo Hsiung ^a   Hsieh, Ling Ling ^a   Huang, Chien Da ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Endobronchial tuberculosis; Matrix metalloproteinase 1; Polymorphism; Stenosis; Taiwanese

Indexed keywords

INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE;

ADULT; ALLELE; ARTICLE; BRONCHOSCOPY; BRONCHUS STENOSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; LUNG BIOPSY; LUNG GRANULOMA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERIPHERAL LYMPHOCYTE; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; TAIWAN; TRACHEA STENOSIS; UPREGULATION;

ADULT; AGED; BASE SEQUENCE; BRONCHI; BRONCHIAL DISEASES; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; TRACHEAL STENOSIS; TUBERCULOSIS, PULMONARY; UP-REGULATION;

EID: 43049106113     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2007.08.010     Document Type: Article

References (30)

1. Hoheisel G., Chan B.K., Chan C.H., Chan K.S., Teschler H., and Costabel U. Endobronchial tuberculosis: diagnostic features and therapeutic outcome. Respir Med 88 (1994) 593-597
2. Hoheisel G., Sack U., Hui D.S., Huse K., Chan K.S., Chan K.K., et al. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis. Tuberculosis (Edinb) 81 (2001) 203-209
3. Han J.K., Im J.G., Park J.H., Han M.C., Kim Y.W., and Shim Y.S. Bronchial stenosis due to endobronchial tuberculosis: successful treatment with self-expanding metallic stent. AJR Am J Roentgenol 159 (1992) 971-972
4. Lincoln E.M., Harris L.C., Bovornkitti S., and Carretero R. The course and prognosis of endobronchial tuberculosis in children. Am Rev Tuberc 74 (1956) 246-255
5. Frostad S. Segmental atelectasis in children with primary tuberculosis. Am Rev Tuberc 79 (1959) 597-605
6. Elkington P.T., Emerson J.E., Lopez-Pascua L.D., O'Kane C.M., Horncastle D.E., Boyle J.J., et al. Mycobacterium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p38 MAPK switch. J Immunol 175 (2005) 5333-5340
7. Elkington P.T., Nuttall R.K., Boyle J.J., O'Kane C.M., Horncastle D.E., Edwards D.R., et al. Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1. Am J Respir Crit Care Med 172 (2005) 1596-1604
8. Rutter J.L., Mitchell T.I., Buttice G., Meyers J., Gusella J.F., Ozelius L.J., et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58 (1998) 5321-5325
9. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning. A laboratory manual. 2nd ed. (1989), Cold Spring Harbor Press, Cold Spring Harbor, NY
10. Joos L., He J.Q., Shepherdson M.B., Connett J.E., Anthonisen N.R., Pare P.D., et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 11 (2002) 569-576
11. Wang C.H., Lin H.C., Liu C.Y., Huang K.H., Huang T.T., Yu C.T., et al. Upregulation of inducible nitric oxide synthase and cytokine secretion in peripheral blood monocytes from pulmonary tuberculosis patients. Int J Tuberc Lung Dis 5 (2001) 283-291
12. Prieto J., Eklund A., and Patarroyo M. Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. Cell Immunol 156 (1994) 191-211
13. Wang C.H., Liu C.Y., Lin H.C., Yu C.T., Chung K.F., and Kuo H.P. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J 11 (1998) 809-815
14. Jormsjo S., Ye S., Moritz J., Walter D.H., Dimmeler S., Zeiher A.M., et al. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ Res 86 (2000) 998-1003
15. Tower G.B., Coon C.C., Benbow U., Vincenti M.P., and Brinckerhoff C.E. Erk 1/2 differentially regulates the expression from the 1G/2G single nucleotide polymorphism in the MMP-1 promoter in melanoma cells. Biochim Biophys Acta 1586 (2002) 265-274
16. Wallace A.M., and Sandford A.J. Genetic polymorphisms of matrix metalloproteinases: functional importance in the development of chronic obstructive pulmonary disease?. Am J Pharmacogenomics 2 (2002) 167-175
17. Murray G.I., Duncan M.E., O'Neil P., Melvin W.T., and Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 2 (1996) 461-462
18. Chambers A.F., and Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89 (1997) 1260-1270
19. Kanamori Y., Matsushima M., Minaguchi T., Kobayashi K., Sagae S., Kudo R., et al. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 59 (1999) 4225-4227
20. Zhu Y., Spitz M.R., Lei L., Mills G.B., and Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61 (2001) 7825-7829
21. Ghilardi G., Biondi M.L., Mangoni J., Leviti S., DeMonti M., Guagnellini E., et al. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 7 (2001) 2344-2346
22. Ye S., Dhillon S., Turner S.J., Bateman A.C., Theaker J.M., Pickering R.M., et al. Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res 61 (2001) 1296-1298
23. Ninomiya S., Niimi T., Shimizu S., Sato S., Achiwa H., Ito H., et al. Matrix metalloproteinase-1 polymorphism of promoter region in sarcoidosis and tuberculosis patients. Sarcoidosis Vasc Diffuse Lung Dis 21 (2004) 19-24
24. Wiencke K., Louka A.S., Spurkland A., Vatn M., Schrumpf E., and Boberg K.M. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol 41 (2004) 209-214
25. Kurzawski M., Drozdzik A., Dembowska E., Pawlik A., Banach J., and Drozdzik M. Matrix metalloproteinase-1 gene polymorphism in renal transplant patients with and without gingival enlargement. J Periodontol 77 (2006) 1498-1502
26. Benbow U., Tower G.B., Wyatt C.A., Buttice G., and Brinckerhoff C.E. High levels of MMP-1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen-activated protein kinases in VMM5 melanoma cells. J Cell Biochem 86 (2002) 307-319
27. Zuo F., Kaminski N., Eugui E., Allard J., Yakhini Z., Ben-Dor A., et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA 99 (2002) 6292-6297
28. Selman M., Ruiz V., Cabrera S., Segura L., Ramirez R., Barrios R., et al. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?. Am J Physiol Lung Cell Mol Physiol 279 (2000) L562-L574
29. Okamoto K., Mimura K., Murawaki Y., and Yuasa I. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. J Gastroenterol Hepatol 20 (2005) 1102-1108
30. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J Biol Chem 274 (1999) 21491-21494